Uric Acid
69-93-2O=c1[nH]c(=O)c2[nH]c(=O)[nH]c2[nH]1LEHOTFFKMJEONL-UHFFFAOYSA-N7,9-dihydro-1H-purine-2,6,8(3H)-trione is an oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8. It has a role as a mouse metabolite, an Escherichia coli metabolite and a human metabolite. It is a tautomer of a 2,6-dihydroxy-7,9-dihydro-8H-purin-8-one, a 9H-purine-2,6,8-triol, a 7H-purine-2,6,8-triol, a 1H-purine-2,6,8-triol and a 5,7-dihydro-1H-purine-2,6,8(9H)-trione.
Greater than 300 °C
> 300 °C
White odorless solid; [Merck Index] Beige powder; [Sigma-Aldrich MSDS]
Solid
126.4 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID3042508]
126.93 Ų [M-H]- [CCS Type: DT; Method: stepped-field]
143.5 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]
130.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 96.8% (30 of 31) of all reports.
Not Classified
Aggregated GHS information provided per 31 reports by companies from 2 notifications to the ECHA C&L Inventory.
Chemical: 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-
REACH registered substance: Uric acid (EC: 200-720-7)
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-: Does not have an individual approval but may be used under an appropriate group standard
Uric acid is a strong reducing agent (donates electrons) and an antioxidant. Normally in humans, one of the main antioxidants in plasma is uric acid. Several animal studies have found that animals given exogenous uric acid within 3 hours after a stroke had decreased infarct volume, improved neurologic function, and diminished inflammatory responses providing evidence for the neuroprotective effects of uric acid. In some early human studies, uric acid has so far shown similar neuroprotective effects, in both the cortex and subcortex areas, due to its antioxidant effects such as decreased lipid peroxidation, and there appears to be no significant toxicities.
69-93-2DTXSID3042508CHEMBL792CHEBI:17775130.5 Ų [M+H]+
化学的特性Uric acid (C5H4O3N4) is a white solid that is insoluble in cold water, alcohol, or ether and sparingly soluble in hot water. It acts as a weak dibasic acid, creating two series of salts, with most being very slightly soluble in water (except for lithium urate, which is soluble).
解説尿酸化学合成もされている."無味,無臭の白い細かい結晶.分解点400 ℃ 以上.d251.836.λmax 207,236,292 nm(ε 14200,9800,2600,pH 8).エーテルに不溶,水に難溶,アルカリ性水溶液に可溶.二価の弱酸で,水溶液に硝酸を加え,蒸発乾固し,アンモニア水を注ぐと赤紫色のムレキシドを生成する(検出反応).また,尿酸はリンタングステン酸を還元して青色を呈する.この反応は尿酸の定量に用いられる.
用途痛風患者では,尿酸の代謝障害のため尿酸の生成が異常に増加し,血液中の量が増大するだけでなく,関節や腎臓に尿酸が沈着する.プリンヌクレオシドなどの合成原料として用いられる.
天然物の起源Uric acid is found in the urine, blood, and muscle juices of carnivorous animals (herbivorous animals secrete hippuric acid), in the excrement of birds, serpents and insects, and is an oxidation product of the complex nitrogenous compounds of the animal organism.
使用Uric Acid is a heterocyclcic compound that is created when purine nucleotides are broken down of by the human body. High blood concetration of Uric Acid is known as hyperuricemia and is often associated with a wide range of disorders and medical conditions such as gout, diabetes and metabolic syndrome. Uric acid may be a marker of oxidative stress and may have a potential therapeutic role as an antioxidant.
使用用途尿酸は研究目的や医薬品用途で使用される物質です。 尿酸はもともと体内で産生される物質であり、血液中の尿酸の濃度 (尿酸値) は「高尿酸血症」の指標として用いられています。高尿酸血症は、体内で尿酸が腎臓から排泄されにくくなったり、尿酸が多く産生されたりすることでおきる病気です。プリン体 (動物性の食品に多く含まれる、プリン骨格を有する物質) を多く含む食品をたくさん摂取することも、病気の一因となります。 男性・女性ともに「尿酸値7.0ミリグラム/デシリットル超」が、高尿酸血症の基準です。一方、尿酸値が「2ミリグラム/デシリットル以下」の場合は一般に「低尿酸血症」と診断されます。低尿酸血症は、体内で尿酸が腎臓から排泄されやすくなったり、尿酸があまり産生されなくなったりすることで生じる病気です。
純化方法Crystallise uric acid from hot distilled H2O (the solubility in H2O is 1part/39,000parts at 18o and 1part/2,000parts at 100o). It is best purified by dissolving in an alkaline solution and acidifying with dilute HCl and drying it at 100o in a vacuum. [Bergmann & Dikstein J Am Chem Soc 77 691 1955, Lister Purines Part II, Fused Pyrimidines Brown Ed, Wiley-Interscience pp256-257 1971, ISBN 0-471-38205-1, Beilstein 26 H 513, 26 I 151, 26 II 293, 26 III/IV 2619.]
定義本品は、次の化学式で表される複素環式化合物である。
定義A nitrogen compound produced from purines. In certain animals (e.g. birds and reptiles), it is the main excretory product resulting from breakdown of amino acids. In humans, uric acid crystals in the joints are the cause of gout.